|
|
The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.
Medication errors are three times higher among children and infants than with adults.
Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.
In most cases, kidneys can recover from almost complete loss of function, such as in acute kidney (renal) failure.
After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

